Results 291 to 300 of about 709,987 (360)
Phase II clinical trial of nirogacestat in patients with relapsed ovarian granulosa cell tumours
Evidence suggests NOTCH activation is among the survival and proliferation pathways interacting with FOXL2 c.402C > G (p.Cys134Trp) mutation in granulosa cell tumours (GCT). This Phase II clinical trial of nirogacestat in GCT achieved its enrolment target in < 1 year and primary analysis within 2 years.
Rachel N. Grisham +20 more
wiley +1 more source
Traumatic Uterine Rupture in Second Trimester: Two Departments, Two Patients, Two Survivors. [PDF]
Kaggwa H +4 more
europepmc +1 more source
Silent uterine rupture in the term pregnancy: Three case reports
Lei Chen +7 more
openalex +1 more source
ABSTRACT This study investigated the effect of monophasic oral contraceptive (OC) use on self‐paced cycling performance, thermoregulation, and skeletal muscle strength and contractile properties in healthy women. Eight physically active women performed 30 min fixed intensity cycling at 50% Wmax, followed by a 30 min self‐paced time trial (TT) with each
Katie James +2 more
wiley +1 more source
This cross‐validation study assessed the comparability of high‐field (HF; 3T) and ultra‐low‐field (ULF; 64mT) volumes in infants for brain regions associated with antenatal maternal anemia. Key findings demonstrated strong agreement between HF and ULF volume estimates for the caudate nucleus, putamen, and corpus callosum in infants between 3 and 18 ...
Jessica E. Ringshaw +16 more
wiley +1 more source
Abstract Objective Prostaglandin regimens for induction of intrauterine fetal death (IUFD) <28 gestational weeks (GW) are unstandardized. We aimed to describe prostaglandin regimens for induction after IUFD and assess association between dose and time to fetal expulsion.
Fanny Berger +3 more
wiley +1 more source
Uterine rupture in labor after prior ultrasound-guided percutaneous microwave ablation of uterine fibroids: A case report. [PDF]
Zeng Y, Wang Y, Guang X.
europepmc +1 more source
Uterine Rupture and Factors Associated with Adverse Outcomes
Stefania K. Finnsdottir
openalex +1 more source
Preterm meconium‐stained amniotic fluid: A red flag for infection and adverse perinatal outcomes
Abstract Objective Meconium‐stained amniotic fluid (MSAF) is uncommon in preterm deliveries and raises concerns about maternal and neonatal infectious risks. We aimed to evaluate maternal, perinatal, and microbiological outcomes in preterm deliveries complicated by MSAF compared to clear amniotic fluid (AF) and to assess outcomes in preterm versus term
Raneen Abu Shqara +3 more
wiley +1 more source
Paradoxical Uterine Rupture and Fetal Survival in Placenta Accreta: A Case Report. [PDF]
Curtis TJ +4 more
europepmc +1 more source

